Skip to main content
. 2014 May 13;93(4):309–319. doi: 10.1111/ejh.12346

Table 4.

Comparison of Puerta de Hierro PNH series with previous published series

First author (yr) (reference) Number of patients Period of study Population site Age of PNH diagnosis Sex Survival & complications Spontaneous remission Patients with aplastic anemia, % Adverse prognostic factors Number of deaths by cancer
Dacie (1972) & Hillmen (1995) 27,29 80 >30 yr London (UK) Hammersmith Hospital 42 (15–75) 33♂/47♀ 60 dead Median survival 10 yr Hemoglobinuria 26% Thrombosis 39% 12 survivors with spontaneous remission 29 NR 1 (lymphoma)
Kruatrachue (1978) 28 85 25 yr Bangkok (Thailand) Siriraj Hospital 30 (10–80) 52♂/23♀ 7 dead Hemoglobinuria 32% Thrombosis 1% Abdominal pain <1% 10 NR None
Socié (1996) 30 220 46 yr France Multicenter 33 (6–82) 100♂/120♀ 71 dead Median survival 15 yr Thrombosis 6% Abdominal pain 13% 30 Age >55 Thrombosis MDS/AML Thrombocytopenia 4 (3 MDS/AML)
Nishimura (2004) 31 385 36 yr (USA) 28 yr (Japan) 176 USA (Duke University) 209 Japan (Multicenter) 30 (4–80) 77♂/99♀ 45 (10–86) 118♂/91♀ Median survival 19 and 32 yr Hemoglobinuria 41% >Thrombosis in USA 19% vs. 6% 33 Age >50 Leukopenia infection thrombosis (USA) Kidney failure (Japan) 13 (9 MDS/AML)
Muñoz-Linares (2013) 56 40 yr Spain Puerta de Hierro Majadahonda Hospital 32 (13–84) 36♂/20♀ 12 dead Median survival 11 yr Hemoglobinuria 60% Thrombosis 35% Abdominal pain 48% 17 survivors with spontaneous remission 67 Thrombosis Esophageal spasms Abdominal pain 5 (Pancreas, lung, hepatocarcinoma, and 2 lymphomas)

AML, acute myeloid leukemia; MDS, myelodysplastic syndrome; NR, not reported; PNH, paroxysmal nocturnal hemoglobinuria.